Zobrazeno 1 - 10
of 10
pro vyhledávání: '"William Petkun"'
Autor:
Ping G Tepper, Jack Mardekian, Cristina Masseria, Hemant Phatak, Shital Kamble, Younos Abdulsattar, William Petkun, Gregory Y H Lip
Publikováno v:
PLoS ONE, Vol 13, Iss 11, p e0205989 (2018)
Limited real-world data are available regarding the comparative safety of non-vitamin K antagonist oral anticoagulants (NOACs). The objective of this retrospective claims observational cohort study was to compare the risk of bleeding among non-valvul
Externí odkaz:
https://doaj.org/article/3c3ffb9f5ad9490ab3aad8225de2f5e5
Autor:
Younos Abdulsattar, William Petkun, Cristina Masseria, Gregory Y.H. Lip, Jack Mardekian, Ping G. Tepper, Shital Kamble, Hemant Phatak
Publikováno v:
PLoS ONE, Vol 13, Iss 11, p e0205989 (2018)
PLOS ONE
PLoS ONE
PLOS ONE
PLoS ONE
Limited real-world data are available regarding the comparative safety of non-vitamin K antagonist oral anticoagulants (NOACs). The objective of this retrospective claims observational cohort study was to compare the risk of bleeding among non-valvul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1ba5ed20a195e869b505d51cb82f822
http://europepmc.org/articles/PMC6211674?pdf=render
http://europepmc.org/articles/PMC6211674?pdf=render
Autor:
Wilson Tan, X. Liu, Daniel E. Singer, William Petkun, Jack Mardekian, Melissa Hamilton, Ping G. Tepper
Publikováno v:
Stroke. 48(6)
Background and Purpose— Stroke risk may increase shortly after warfarin initiation in nonvalvular atrial fibrillation patients. Because of the brief period and limited number of events, large samples are needed to study this effect. We compared 30-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::452d8632a9a37a7897828054740db187
https://pubmed.ncbi.nlm.nih.gov/28739884
https://pubmed.ncbi.nlm.nih.gov/28739884
Autor:
William Petkun, Shital Kamble, Jack Mardekian, Cristina Masseria, Yaniv Ravee, Gregory Y.H. Lip, Phatak Hemant, Ping G. Tepper, Younous Abdulsattar
Publikováno v:
Circulation. 132
Background: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia [1-3] with increasing prevalence in the aging [4]. With the advent of the three NOACs including apixaban, dabigatran and rivaroxaban, it is important to characterize
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1c1cf50d0fc835124ab6bd9fb6daf3a
https://doi.org/10.1161/circ.132.suppl_3.19941
https://doi.org/10.1161/circ.132.suppl_3.19941
Autor:
Cristina Masseria, Shital Kamble, Hemant Phatak, Younous Abdulsattar, Yaniv Ravee, William Petkun, Jack Mardekian
Publikováno v:
Circulation. 132
Background: Non-valvular atrial fibrillation (NVAF) was commonly treated with warfarin. With the introduction of Non-Vitamin K Oral Anticoagulants (NOACs) in the United States, some patients are switching from standard of care to NOACs Purpose: To in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4dee7b10841214342e0ac5e3d28c090f
https://doi.org/10.1161/circ.132.suppl_3.19828
https://doi.org/10.1161/circ.132.suppl_3.19828
Autor:
Ping G Tepper, Xianchen Liu, Hamilton Melissa, Jack Mardekian, William Petkun, Wilson Tan, Daniel E Singer
Publikováno v:
Stroke. 45
Objective: Studies suggest that warfarin may increase the risk of stroke in the first month after initiation among atrial fibrillation (AF) patients. This study assess whether there is a similar occurrence with major bleeds. We compared rates of majo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f189dbb05c68bff357e2327b91827cd
https://doi.org/10.1161/str.45.suppl_1.wp309
https://doi.org/10.1161/str.45.suppl_1.wp309
Publikováno v:
Stroke. 44
OBJECTIVES: To determine the frequency of initial atrial fibrillation (AF) diagnosis prior to, concurrent with, or subsequent to incident ischemic stroke and ischemic stroke or transient ischemic attack (TIA). METHODS: A large healthcare claims datab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::085383eb5ee9e0538d01283632968001
https://doi.org/10.1161/str.44.suppl_1.atp388
https://doi.org/10.1161/str.44.suppl_1.atp388
Autor:
Cristina Masseria, Melissa Hamilton, Ping Tepper, Younos Abdulsattar, Shital Kamble, William Petkun, Ruslan Horblyuk, Jack Mardekian, Gregory Y.H. Lip
Publikováno v:
Journal of the American College of Cardiology. 67:662
Information about the risk of bleeding and bleeding-related resource use and costs among non-Vitamin K antagonist oral anticoagulants (NOACs) in the real-world setting is scarce. This study aim was to compare inpatient bleeding risks, bleeding-relate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d41c72e34e2659a6c429ae62a7540fd
https://doi.org/10.1016/s0735-1097(16)30663-5
https://doi.org/10.1016/s0735-1097(16)30663-5
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 5
Background: Estimates from epidemiologic studies projecting the prevalence of atrial fibrillation (AF) in the US have varied widely in the literature, ranging from 2.7 million cases to 6.1 million cases for 2010. While the prevalence of AF is increas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c369efb4f45209a8d57694245f442ec
https://doi.org/10.1161/circoutcomes.5.suppl_1.a206
https://doi.org/10.1161/circoutcomes.5.suppl_1.a206
Autor:
William Petkun, Charles V. Pollack, Jonas Oldgren, Judith Spahr, Paul Sanders, Paulus Kirchhof, Andrei Breazna, Michael D. Ezekowitz, Jonathan L. Halperin, Nilo B. Cater
Publikováno v:
American Heart Journal. :59-68
BackgroundStroke prevention in anticoagulation-naïve patients with atrial fibrillation undergoing cardioversion has not been systematically studied.ObjectiveTo determine outcomes in anticoagulation-naïve patients (defined as those receiving an anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0a4fbf1b6a9279dd8a8acb7f1c5c053